Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $554.17 Consensus Price Target from Analysts

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned a consensus rating of “Moderate Buy” from the nineteen research firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the company. The average 1-year price target among analysts that have covered the stock in the last year is $554.17.

ISRG has been the topic of several recent analyst reports. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Stifel Nicolaus lifted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 11th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Mizuho lifted their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th.

Intuitive Surgical Stock Up 1.3 %

Intuitive Surgical stock opened at $542.37 on Thursday. Intuitive Surgical has a 12-month low of $324.12 and a 12-month high of $556.23. The stock has a market cap of $193.18 billion, a price-to-earnings ratio of 87.20, a P/E/G ratio of 5.31 and a beta of 1.39. The business’s 50-day simple moving average is $533.39 and its 200 day simple moving average is $492.20.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. As a group, sell-side analysts expect that Intuitive Surgical will post 5.45 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock worth $25,012,927 over the last quarter. Company insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several large investors have recently modified their holdings of the stock. Capital Market Strategies LLC increased its holdings in Intuitive Surgical by 7.8% in the 4th quarter. Capital Market Strategies LLC now owns 1,237 shares of the medical equipment provider’s stock valued at $646,000 after buying an additional 90 shares during the period. Nordea Investment Management AB boosted its holdings in shares of Intuitive Surgical by 31.7% in the 4th quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider’s stock valued at $22,632,000 after purchasing an additional 10,405 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Intuitive Surgical by 10.0% during the 4th quarter. GAMMA Investing LLC now owns 5,597 shares of the medical equipment provider’s stock worth $2,921,000 after buying an additional 507 shares in the last quarter. Versant Capital Management Inc lifted its position in shares of Intuitive Surgical by 27.4% during the 4th quarter. Versant Capital Management Inc now owns 688 shares of the medical equipment provider’s stock worth $359,000 after buying an additional 148 shares during the last quarter. Finally, SMART Wealth LLC bought a new position in Intuitive Surgical in the third quarter valued at about $290,000. 83.64% of the stock is owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.